Novartis plans inclisiran’s primary prevention study in UK
Novartis plans to make UK the global centre for its new inclisiran study. Credit: Novartis AG.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more